Home/Longeveron/Joshua Hare, M.D.
JH

Joshua Hare, M.D.

Co-founder, Chief Science Officer, Chairman

Longeveron

Longeveron Pipeline

DrugIndicationPhase
Laromestrocel (Lomecel-B™)Hypoplastic Left Heart Syndrome (HLHS)Phase 2b